Accountability should be shared, but not blurred. Healthcare security teams, clinical operators, and medical device manufacturers all have defined roles. Providers must enforce onboarding, monitoring, and credential discipline. Manufacturers must build secure-by-design devices with unique identities and signed firmware. When ownership is unclear, gaps appear at the handoff points where breaches most often start.
Who Holds Accountability Across the Device Lifecycle?
connected medical device are a shared accountability problem, but the share is not equal. Providers own day-to-day operational control once devices enter clinical use; manufacturers own secure design, identity, firmware integrity, and patchability; and clinical leadership owns safe deployment decisions. The practical answer is to assign clear owners for each lifecycle stage, not to rely on a single security team to carry the whole burden.
Accountability has to follow the device from procurement to retirement because the risk changes at each handoff. A device that is secure in the lab can become unsafe in the ward if ownership, inventory, or update responsibility is not explicit. In practice, the most durable model is one that links technical controls to named operational owners, then forces escalation when those owners cannot act.
That division matters because the security problem is rarely only technical. It is also operational, contractual, and clinical. If no one owns credential rotation, firmware validation, network placement, or removal from service, the device may remain connected long after its security assumptions have broken down.
Why the Handoff Points Matter More Than the Initial Deployment
The highest-risk moments are usually onboarding, change, and decommissioning. Those are the points where devices are registered, credentials are issued, updates are approved, and support boundaries are drawn. If those steps are undocumented or split across teams, the organisation may end up with orphaned devices, stale access paths, or unsupported software that still reaches clinical networks.
Manufacturers influence that risk before the device ships. Secure defaults, unique device identities, signed updates, and clear support lifecycles reduce the chance that the provider inherits an unmanageable asset. Providers then decide whether the device is allowed onto the network, how it is monitored, and who can change its configuration. Clinical teams are responsible for using it in a way that does not defeat those controls.
Ownership also affects incident response. If the security team detects suspicious traffic from a device but no one can confirm the owner, support contact, or patch path, containment becomes slower and more disruptive. That is why lifecycle accountability is not just a governance concept, it is a control that determines whether the organisation can act quickly under pressure.
What Good Accountability Looks Like in Practice
Good accountability is specific, documented, and enforceable. Each connected device should have a business owner, a technical owner, a clinical owner where relevant, and a manufacturer support path that remains valid for the full support window. The provider should control onboarding, network access, monitoring, and retirement. The manufacturer should control secure engineering, update signing, vulnerability disclosure, and product maintenance.
The practical test is simple: if a device fails, expires, or is compromised, can the organisation answer who approves continued use, who rotates credentials, who isolates the device, and who signs off on retirement? If the answer is unclear, accountability is already failing. Teams should also be able to prove that inventory records, support status, and access ownership are current, because a device you cannot find or classify is a device you cannot govern.
For systems with shared responsibility, the safest structure is explicit handover documentation. That includes support boundaries, update responsibility, exception handling, and escalation contacts. Without that, “shared” accountability often becomes “nobody” in practice.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-53 Rev 5, CSA Cloud Controls Matrix and CIS Controls v8 set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-53 Rev 5 | IA-5 — Authenticator Management | Lifecycle ownership of device credentials directly depends on issuer, rotation, and revocation controls. |
| CM-8 — System Component Inventory | The answer depends on knowing which devices exist, who owns them, and whether they remain supported. | |
| Recommendation — Enforce credential issuance, rotation, and revocation for connected medical devices. Maintain an accurate inventory of connected medical devices with owners and support status. | ||
| ISO/IEC 27001:2022 | A.5.9 — Inventory of information and other associated assets | Device accountability requires an owned, current inventory across the full lifecycle. |
| Recommendation — Keep a current asset inventory that assigns each medical device to an accountable owner. | ||
| CSA Cloud Controls Matrix | IAM — Identity and Access Management | Connected devices need controlled identities, access paths, and lifecycle governance. |
| Recommendation — Apply IAM controls to device identities, access paths, and lifecycle ownership. | ||
| CIS Controls v8 | CIS-1 — Inventory and Control of Enterprise Assets | Lifecycle accountability starts with discovering and tracking every connected device. |
| Recommendation — Inventory and track all connected medical devices and their ownership status. | ||
Practitioner Guidance
What to prioritise: Start with ownership and inventory before trying to perfect technical controls. If you cannot tie each connected medical device to an accountable owner and a current support state, monitoring and patching will remain incomplete.
What to verify: Confirm that onboarding, firmware signing, credential rotation, network placement, exception approval, and retirement all have named owners. The key question is whether those owners can actually act when the device is vulnerable or no longer supported.
Common mistake: Treating the biomedical, clinical, and security functions as separate silos. That usually leaves one of them assuming another group will handle updates, logging, or offboarding, which is where risk accumulates.
Practitioner takeaway: Accountability for connected medical devices should be distributed by lifecycle stage, but each stage must have one clear decision-maker. Shared responsibility works only when the handoffs are explicit and operationally testable.
Related resources from NHI Mgmt Group
- How should healthcare security teams use pentesting to reduce ransomware risk across connected systems and medical devices?
- How should healthcare organisations reduce breach risk across EHRs, connected medical devices, and third-party access?
- How should security teams make NHI best practices usable across the business?
- How should teams govern asset lifecycle workflows across users and devices?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 26, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
